While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives
As a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus, liraglutide improves endothelial dysfunction caused by hyperglycemia, thereby preventing angiogenesis disorders in C57BLKs/J mice of wound model
Store in a safe place, away from children's reach
Controlled Release
Strbe et al., 2021), the and combined score (08) = the sum of the analyzed affected areas (04) and karyopyknotic cells in the brain areas (04), as follows
A total of 47,036 records were identified through a systematic search of PubMed